<DOC>
	<DOCNO>NCT02234128</DOCNO>
	<brief_summary>This safety study compare safety receive lung treat Toronto EVLP System™ SPONSOR SPONSOR 's dedicate facility standard lung transplantation .</brief_summary>
	<brief_title>Extending Preservation Assessment Time Donor Lungs Using Toronto EVLP System™ Dedicated EVLP Facility</brief_title>
	<detailed_description>Human donor lung allocate participate study transplant center ( Study Center ) specific recipient meeting study EVLP donor lung inclusion/exclusion criterion assess SPONSOR inclusion study . Upon retrieval , donor lung ( ) package transport ice SPONSOR 's EVLP facility Silver Spring , Maryland , differently lung recover , package , transport transplant center implantation . The EVLP procedure perform Certified Ex Vivo Lung Specialists use Toronto EVLP System™ 6 hour , collect relay lung function assessment data hourly request Study Center transplant surgeon . Additionally , Study Center surgeon capability evaluate lung function data monitor procedure remotely dedicate video link . Upon acceptance EVLP donor lung Study Center , single lung lung block cool Toronto EVLP System™ 10 degree C. Thereafter , perfusion ventilation stop lung prepared hypothermic storage transport accept Study Center .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>Subject In order eligible participate study , individual must meet following criterion : Male female patient All patient , 18 year age old Patient already add active wait list single bilateral lung transplant Patient patient 's representative provide informed consent participation study time study commencement time list transplant Patient patient 's representative reconfirms inform consent study day lung transplant Subject A subject meet follow criterion exclude participation : Patients list sameside lung retransplantation Patients list multiple organ transplantation include lung organ Patients list live donor lobar transplant Patients HIV , active Hepatitis B/C , Burkholderia Cepacia Patients initially consent study prior time lung transplant Patients ICU time initial lung offer require mechanical ventilation , ECMO Extracorporeal life support ( ECLS ) . Donor Lung Inclusion Criteria EVLP Assessment : The donor lung must meet least one follow criterion proceed EVLP : At time clinical evaluation , donor PaO2/FiO2 &lt; 300 mmHg Donor receive ≥ 10 unit blood transfusion Donation Cardiac Death ( DCD ) donor Expected cold ischemic time &gt; 6 hour Donor age ≥ 55 year old Study Center Investigator require additional assessment ex vivo and/or extend preservation time Donor Lung Exclusion Criteria EVLP Assessment : The donor lung exclude EVLP least one follow criterion meet : The donor lung confirm pneumonia and/or persistent purulent secretion identify via bronchoscopy Nonpersistent purulent secretion clear hour 3 EVLP The donor lung confirm evidence aspiration The donor lung significant mechanical lung injury trauma The cold ischemic time , start donor aortic cross clamp/ initial flush ( CIT1 ) , require transport lung donor site start EVLP procedure SPONSOR 's facility &gt; 10 hour EVLP Lung Inclusion Criteria Transplantation : The donor lung must meet following condition postEVLP transplant suitability consideration Study Center Investigator : PvO2/FiO2 ≥ 350 mmHg final EVLP evaluation time period &lt; 15 % increase baseline value ( define first hour collection point ) final value pulmonary vascular resistance ( PVR ) &lt; 15 % increase baseline value final value peak airway pressure ( PawP ) &lt; 15 % decrease baseline value final value static lung compliance ( Cstat ) total preservation time ( TPT ) exceed follow : initial CIT1 time donor EVLP &gt; 1 hour ≤ 10 hour EVLP time &gt; 3 hour ≤ 6 hour second CIT2 EVLP cool begin recipient implantation must &gt; 1 hour ≤ 6 hour first lung second CIT2 EVLP cool begin recipient implantation must &gt; 1 hour ≤ 10 hour second lung Study Center Investigator deem lung function suitable intend subject EVLP Lung Exclusion Criteria Transplantation : The donor lung exclude transplant inclusion least one follow criterion meet : PvO2/FiO2 &lt; 350 mmHg final EVLP evaluation time period ≥ 15 % increase baseline value final value pulmonary vascular resistance ( PVR ) ≥ 15 % increase baseline value final value peak airway pressure ( PawP ) ≥ 15 % decrease baseline value final value static lung compliance ( Cstat ) TPT exceed follow condition : CIT1 &lt; 1 hour &gt; 10 hour EVLP &lt; 3 hour &gt; 6 hour CIT2 &lt; 1 hour &gt; 6 hour first lung &gt; 10 hour second lung Study Center investigator deem lung function unsuitable intend subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Ex Vivo Lung Perfusion</keyword>
	<keyword>EVLP</keyword>
	<keyword>Lung Transplant</keyword>
	<keyword>Lung Transplantation</keyword>
	<keyword>Toronto EVLP System™</keyword>
	<keyword>PERFUSIX</keyword>
</DOC>